Signal Radar Weekly | 21 – 27 September 2026
A wider manufacturing or supplier base needs processes that new teams can reproduce reliably.
What happened this week
A company planning a new factory usually asks where it wants to manufacture. For a business still solving production problems, that can be the second question. The first is where its engineers can turn a promising design into something they can make reliably.
Those locations need not be the same. A place with equipment specialists nearby may help a young process develop faster, even if the company ultimately wants production closer to customers or spread across several countries. Moving too early can mean paying to solve the same problems again. Staying indefinitely can leave the business dependent on the original team and suppliers.
This week’s Signal Radar examines the decision between those two stages. A successful first line would show that production is possible there. Expansion needs evidence that the capability can travel.
That is a practical supply chain resilience question. The next investment may need to buy the ability to reproduce a process before it buys another building. A location strategy becomes more useful when it states how the company will move from learning to dependable production elsewhere.
Signal Radar is being built to help teams connect emerging supply chain risks with commercial and operational decisions. We are opening selected MVP and beta access for operators, analysts and leaders who want to test the product and shape what comes next.
The Bigger Pattern
More spending does not automatically produce more usable supply. Permanent investment needs evidence of a lasting constraint, while better commercial terms can weaken a supplier’s ability or willingness to deliver. Both point to the same discipline: establish what will improve the supply you can rely on before making a commitment harder to reverse.
A wider supplier list can also leave the underlying exposure unchanged. Different suppliers may depend on the same constrained infrastructure, so a business can diversify its purchasing relationships while remaining exposed to one shared passage.
The next question is when retaining a concentrated dependency has a useful purpose. During development, a group of specialists may help a process become viable. Later, dependence on that same group may limit where it can be reproduced. The judgement changes with the work being done.
This extends the existing argument about usable alternatives. Counting another factory as independent supply is premature if it still needs the first site to keep operating. The investment decision needs to distinguish establishing a capability from making that capability transferable.
What Changed
Engineering support shapes the first factory
Reuters’ account of EnerVenue’s first factory in Changzhou makes the development stage unusually visible. Mass production was scheduled for 24 September. The CEO describes nearby equipment suppliers and rapid engineering changes; a floor manager describes suppliers sometimes deferring payment until equipment is adopted. These are advantages in solving a production problem, rather than simply purchasing a finished design at a lower price.
The company plans further regional factories from 2028, with locations to be chosen in 2027. Its earlier Kentucky project had already been abandoned, and the battery and factory were subsequently redesigned. Comparing the two project budgets therefore cannot establish a like-for-like location saving. Nor does the announced start establish reliable mass production. The evidence explains why the company chose this setting for development; it does not yet show that the process works reliably or can move elsewhere.
Other constraints need different responses
Other developments help define the limits of that interpretation. INEOS reported two Hull acetyls plants already stopped and a third due to follow, citing gas costs. These plants make chemical ingredients. Here the reported obstacle is the economics of operating existing production, rather than learning how to manufacture. Engineering capability alone cannot make the next batch commercially worthwhile. The company gives no restart date.
In transport, ZET Scale announced an initial order for 2,500 electric heavy trucks, with ZET Financial issuing the purchase order. The programme combines shipper demand, leasing and charging hubs. Its proposal concerns coordinating the workload and resources for a new service. Vehicle deliveries, individual binding shipper commitments and realised service costs remain unverified. The number of trucks ordered cannot establish that a particular route will work.
Finally, Lilly broke ground on its Houston manufacturing site. Investment in US production continues, although construction is not current supply. EnerVenue’s account does not justify a general verdict on the best country for manufacturing. It supports a narrower question about the stage of the process and the capabilities needed to advance it.
Why It Matters
Test what the receiving team needs
For a manufacturer approving expansion, put two decisions on the investment agenda. One concerns the desired footprint: customer access, location and dependence on existing sites. The other concerns whether the process is ready to operate in that footprint. A commercially attractive location can still be premature for a process that changes every time engineers run it.
This changes the next use of scarce technical effort. Before committing to another building, establish which parts of production depend on particular people, equipment suppliers or working methods. Then decide what must be available to the receiving team. The answer may support expansion, a transfer trial or further work at the first site.
Procurement faces the same distinction when qualifying a young supplier. A promise of several future factories should not carry more weight than evidence from the line expected to fulfil the order. The buyer needs to understand which capacity can support its delivery plan now and which still depends on development.
Know when further delay stops helping
There is a cost to waiting as well. A mature process may be ready to expand, and repeatedly demanding more proof can delay useful capacity. The objective is to resolve the uncertainty that could change the decision. Once another team can reproduce the required output with the support it will receive, the case for keeping expansion funds in reserve becomes weaker.
Supply chain planning should reflect that distinction: expected future capacity and demonstrated supply have different jobs in the plan.
Signal Strength
The evidence supports a distinction between developing production and reproducing it. EnerVenue provides a detailed account of why engineering collaboration mattered to its first-site choice. It is one company’s experience, with successful operation and transfer still to be demonstrated.
INEOS and ZET show why that explanation should not be applied to every capacity problem. Their disclosed constraints concern operating economics and service coordination. Lilly’s construction milestone also limits any conclusion that one geography has become unsuitable for investment.
Current assessment: Medium. The development-versus-expansion argument is credible and useful, but its prevalence and results are unmeasured.
Direction: Stable. This is a refinement of earlier analysis about dependencies and investment, with limited comparable evidence for judging whether the specific pattern is strengthening. It is not an assessment of overall supply chain risk.
Questions To Ask This Week
Logistics
- Which new service in the plan still depends on unfinished equipment or infrastructure?
Procurement
- Does the next supplier award rely on demonstrated output or promised future factories?
Planning & Inventory
- Which forecast deliveries depend on a factory reaching its planned output?
Commercial
- Which customer dates assume new capacity will start on schedule?
Finance
- Does the next approval fund further development, a transfer trial or repeat production?
Operations
- What would another team need to reproduce the first line’s performance?
What We’re Watching Next
The most useful next evidence will show what happens after the first production start. Stable output at the required quality and cost would support the case for testing replication. Continuing redesign would indicate that more of the manufacturing problem remains to be solved.
Successful transfer to a different team would answer a separate question. It would show which capability can move and which support still has to remain connected to the original site. If comparable performance can be achieved with readily available support, the case for delaying expansion weakens.
These results would improve the investment decision more than another announced plant. Before approving duplicate equipment, ask the receiving team to demonstrate the process using the instructions, skills and supplier support it will actually have.